Business Description
Rapid Dose Therapeutics Corp
NAICS : 325412
SIC : 3741
ISIN : CA75339A1012
Description
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | -2.28 | |||||
| Debt-to-Equity | -0.61 | |||||
| Debt-to-EBITDA | -1.18 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -31.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 91.3 | |||||
| 3-Year EBITDA Growth Rate | 33.9 | |||||
| 3-Year EPS without NRI Growth Rate | 24.8 | |||||
| 3-Year FCF Growth Rate | 47.7 | |||||
| 3-Year Book Growth Rate | -135.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.21 | |||||
| 9-Day RSI | 27.33 | |||||
| 14-Day RSI | 35.18 | |||||
| 6-1 Month Momentum % | -78.43 | |||||
| 12-1 Month Momentum % | 37.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.1 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 117.77 | |||||
| Days Sales Outstanding | 28.36 | |||||
| Days Payable | 2057.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | -3.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.76 | |||||
| Operating Margin % | -292.82 | |||||
| Net Margin % | -342.87 | |||||
| FCF Margin % | -102.59 | |||||
| ROA % | -160.7 | |||||
| ROIC % | -103.18 | |||||
| ROC (Joel Greenblatt) % | -179.19 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 22.78 | |||||
| EV-to-EBIT | -7.87 | |||||
| EV-to-EBITDA | -10.31 | |||||
| EV-to-Revenue | 23.07 | |||||
| EV-to-FCF | -22.34 | |||||
| Earnings Yield (Greenblatt) % | -12.71 | |||||
| FCF Yield % | -5.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RDTCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rapid Dose Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.772 | ||
| EPS (TTM) ($) | -0.033 | ||
| Beta | 2.51 | ||
| Volatility % | 3030.13 | ||
| 14-Day RSI | 35.18 | ||
| 14-Day ATR ($) | 0.005212 | ||
| 20-Day SMA ($) | 0.0151 | ||
| 12-1 Month Momentum % | 37.27 | ||
| 52-Week Range ($) | 0.0021 - 0.2932 | ||
| Shares Outstanding (Mil) | 104.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rapid Dose Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rapid Dose Therapeutics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rapid Dose Therapeutics Corp Frequently Asked Questions
What is Rapid Dose Therapeutics Corp(RDTCF)'s stock price today?
The current price of RDTCF is $0.02. The 52 week high of RDTCF is $0.29 and 52 week low is $0.00.
When is next earnings date of Rapid Dose Therapeutics Corp(RDTCF)?
The next earnings date of Rapid Dose Therapeutics Corp(RDTCF) is .
Does Rapid Dose Therapeutics Corp(RDTCF) pay dividends? If so, how much?
Rapid Dose Therapeutics Corp(RDTCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers